XML 47 R3.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated balance sheets - EUR (€)
€ in Millions
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Assets      
Property, plant and equipment € 9,869 € 10,028 € 9,365 [1]
Right-of-use assets 1,815 1,948 1,198 [1]
Goodwill 49,892 48,056 44,364 [1]
Other intangible assets 21,640 21,407 18,341 [1]
Investments accounted for using the equity method 677 250 201 [1]
Other non-current assets 3,095 3,127 2,734 [1]
Non-current income tax assets 242 175 248 [1]
Deferred tax assets 5,381 4,598 4,176 [1]
Non-current assets 92,611 89,589 80,627 [1]
Inventories 8,960 8,715 8,352 [1]
Accounts receivable 8,424 7,568 7,491 [1]
Other current assets 3,532 3,571 2,737 [1]
Current income tax assets 374 612 1,208 [1]
Cash and cash equivalents 12,736 10,098 13,915 [1],[2]
Current assets 34,026 30,564 33,703 [1]
Assets held for sale or exchange 85 89 83 [1]
Total assets 126,722 120,242 114,413 [1]
Equity and liabilities      
Equity attributable to equity holders of Sanofi 74,784 68,681 63,106 [3]
Equity attributable to non-controlling interests 368 350 146 [3]
Total equity 75,152 69,031 63,252 [3]
Long-term debt 14,857 17,123 19,745 [3]
Non-current lease liabilities 1,904 1,839 931 [3]
Non-current liabilities related to business combinations and to non-controlling interests 674 577 387 [3]
Non-current provisions and other non-current liabilities 6,341 6,721 7,315 [3]
Non-current income tax liabilities 1,979 2,039 1,733 [3]
Deferred tax liabilities 1,841 1,617 1,770 [3]
Non-current liabilities 27,596 29,916 31,881 [3]
Accounts payable 6,813 6,180 5,295 [3]
Current liabilities related to business combinations and to non-controlling interests 105 137 218 [3]
Current provisions and other current liabilities 12,021 11,217 10,132 [3]
Current income tax liabilities 574 309 604 [3]
Current lease liabilities 277 269 232 [3]
Short-term debt and current portion of long-term debt 4,174 3,183 2,767 [3]
Current liabilities 23,964 21,295 19,248 [3]
Liabilities related to assets held for sale or exchange 10 0 32 [3]
Total equity and liabilities € 126,722 € 120,242 € 114,413 [3]
[1] Includes the impacts of the IFRIC final agenda decisions of March 2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April 2021 on the attribution of benefits to periods of service, as described in Note A.2.1. to the consolidated financial statements for the year ended December 31, 2021.
[2] (j)    Includes the impacts of the IFRIC final agenda decisions of March 2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April 2021 on the attribution of benefits to periods of service, as described in Note A.2.1. to the consolidated financial statements for the year ended December 31, 2021.
[3] Includes the impacts of the IFRIC final agenda decisions of March 2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April 2021 on the attribution of benefits to periods of service, as described in Note A.2.1. to the consolidated financial statements for the year ended December 31, 2021.